These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23953580)

  • 1. Small interfering RNA targeting nuclear factor kappa B to prevent vein graft stenosis in rat models.
    Meng XB; Bi XL; Zhao HL; Feng JB; Zhang JP; Song GM; Sun WY; Bi YW
    Transplant Proc; 2013; 45(6):2553-8. PubMed ID: 23953580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of RAGE in aminoguanidine-induced suppression of venous intimal hyperplasia in diabetic rats.
    Wang X; Diao Y; Zhang H; Huo X; Zhang Q
    Ann Vasc Surg; 2009 Mar; 23(2):246-54. PubMed ID: 19110400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
    Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
    J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous vein graft stenosis inhibited by orphan nuclear receptor Nur77-targeted siRNA.
    Liu K; Zhou W; Chen H; Pan H; Sun X; You Q
    Vascul Pharmacol; 2015 Oct; 73():64-70. PubMed ID: 26276525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting.
    Zhu Z; Xu R; Zheng X; Wang T; Li D; Wang Y; Liu K
    Vasc Endovascular Surg; 2016 Oct; 50(7):464-469. PubMed ID: 27681173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small interfering RNA to c-myc inhibits vein graft restenosis in a rat vein graft model.
    Wang J; Liu K; Shen L; Wu H; Jing H
    J Surg Res; 2011 Jul; 169(1):e85-91. PubMed ID: 21571310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The gene expression of nuclear transcriptional factor-kappa B and I kappa B in autogenous vein graft in rats].
    Hu X; Zhang Q; Sun D; Duan P; Wang X; Duan Z
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1546-9. PubMed ID: 12609064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signaling 3 is a negative regulator for neointimal hyperplasia of vein graft stenosis.
    Xiang S; Liu J; Dong N; Shi J; Xiao Y; Wang Y; Hu X; Gong L; Wang W
    J Vasc Res; 2014; 51(2):132-43. PubMed ID: 24685947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of microRNA-145 to prevent vein graft disease in rabbits by regulation of smooth muscle cell phenotype.
    Ohnaka M; Marui A; Yamahara K; Minakata K; Yamazaki K; Kumagai M; Masumoto H; Tanaka S; Ikeda T; Sakata R
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):676-82.e2. PubMed ID: 24507892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
    Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of NF-kappaB p65 expression attenuates delayed xenograft rejection.
    Shen Z; Ye W; Ten X
    Xenotransplantation; 2013; 20(2):123-30. PubMed ID: 23489828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
    Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of human tissue factor pathway inhibitor gene transfection on neointima formation in vein grafts].
    Li Q; Zhang K; Jiang X; Sun T; Wu L; Zhou C; Chen S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Mar; 22(3):354-8. PubMed ID: 18396721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adventitial delivery of platelet-derived endothelial cell growth factor gene prevented intimal hyperplasia of vein graft.
    Handa M; Li W; Morioka K; Takamori A; Yamada N; Ihaya A
    J Vasc Surg; 2008 Dec; 48(6):1566-74. PubMed ID: 18848756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atelocollagen-mediated small interfering RNA delivery for effective gene silencing in rat vein grafts].
    Qiu XF; Dong NG; Sun ZQ; Su W; Shi JW
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):1028-31. PubMed ID: 19957819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of heart NF-κB p65 expression by jugular vein injection of RNAi in mice.
    Ye W; Ten X; He M; Yu Y; Huang H; Hu Y; Chen Y; Zhou X; Shen Z
    Methods Find Exp Clin Pharmacol; 2010; 32(6):391-400. PubMed ID: 20852747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
    Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
    J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of monocyte chemoattractant protein-1 by adenoviral gene transfer inhibits experimental vein graft neointimal formation.
    Tatewaki H; Egashira K; Kimura S; Nishida T; Morita S; Tominaga R
    J Vasc Surg; 2007 Jun; 45(6):1236-43. PubMed ID: 17543688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual regulation of tumor necrosis factor-alpha-induced CCL2/monocyte chemoattractant protein-1 expression in vascular smooth muscle cells by nuclear factor-kappaB and activator protein-1: modulation by type III phosphodiesterase inhibition.
    Chen YM; Chiang WC; Lin SL; Wu KD; Tsai TJ; Hsieh BS
    J Pharmacol Exp Ther; 2004 Jun; 309(3):978-86. PubMed ID: 14978197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.